GSK Investigational Site

Hattiesburg, Mississippi 39404

0 studies enrolling now · 7 studies all time

What they study most

Epilepsy, Partial, Fallopian Tube Cancer, Insomnia, Migraine Disorders, Migraine, Acute, Nausea, Nausea and Vomiting, Chemotherapy-Induced, Neoplasms, Ovarian, Neoplasms, Prostate, Ovarian Cancer, Peritoneal Cancer, Sleep Initiation and Maintenance Disorders

Studies at this site

• Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer — Completed
• SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy — Completed
• Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
• Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia — Completed
• Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting — Completed
• TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults — Completed